Literature DB >> 22589286

Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops.

Luigi Padeletti1, Paolo Pieragnoli, Giuseppe Ricciardi, Laura Perrotta, Gino Grifoni, Maria Cristina Porciani, Vincenzo Lionetti, Sergio Valsecchi.   

Abstract

BACKGROUND: During cardiac resynchronization therapy (CRT) device implantation, the pacing lead is usually positioned in the coronary sinus (CS) to stimulate the left ventricular (LV) epicardium. Transvenous LV endocardial pacing via transseptal puncture has been proposed as an alternative method. In the present study, we evaluated the acute hemodynamic effects of CRT through LV endocardial pacing in heart failure patients by analyzing LV pressure-volume relationships. METHODS AND
RESULTS: LV pressure and volume data were determined via conductance catheter during CRT device implantation in 10 patients. In addition to the standard epicardial CS pacing, the following endocardial LV sites were systematically assessed: the site transmural to the CS lead, the LV apex, the septal midwall, the basal lateral free wall, and the midlateral free wall. Four atrioventricular delays were tested. There was a significant improvement of systolic function with CRT in all LV pacing configurations, whereas no differences in systolic or diastolic function were detected between LV epicardial and endocardial transmural sites. The optimal pacing site varied among patients but was rarely related to relatively longer activation delays, as assessed by analyzing endocardial electric activation maps. Nonetheless, positioning the pacing lead at the optimal endocardial LV site in each patient significantly improved LV performance in comparison with conventional CS site stimulation (stroke volume, 83 [79-112] mL versus 73 [62-89] mL; P=0.034).
CONCLUSIONS: Pacing at the optimal individual LV endocardial site yields enhanced LV performance in comparison with conventional CS site stimulation. Endocardial LV pacing might constitute an alternative approach to CRT, when CS pacing is not viable.

Entities:  

Mesh:

Year:  2012        PMID: 22589286     DOI: 10.1161/CIRCEP.111.970277

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  16 in total

Review 1.  Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Authors:  Sokratis Pastromas; Antonis S Manolis
Journal:  World J Cardiol       Date:  2014-12-26

Review 2.  His-Bundle Pacing and LV Endocardial Pacing as Alternatives to Traditional Cardiac Resynchronization Therapy.

Authors:  Pugazhendhi Vijayaraman; Faiz A Subzposh
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

3.  Pacing and Defibrillators in Complex Congenital Heart Disease.

Authors:  Henry Chubb; Mark O'Neill; Eric Rosenthal
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

4.  Cardiac resynchronization therapy update: evolving indications, expanding benefit?

Authors:  C Butcher; Y Mareev; V Markides; M Mason; T Wong; J G F Cleland
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 5.  Optimizing CRT - Do We Need More Leads and Delivery Methods.

Authors:  Pieter Martens; Frederik Hendrik Verbrugge; Wilfried Mullens
Journal:  J Atr Fibrillation       Date:  2015-04-30

6.  Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions.

Authors:  Nadeev Wijesuriya; Mark K Elliott; Vishal Mehta; Baldeep S Sidhu; Marina Strocchi; Jonathan M Behar; Steven Niederer; Christopher A Rinaldi
Journal:  Front Physiol       Date:  2022-06-06       Impact factor: 4.755

Review 7.  Electromechanical dyssynchrony and resynchronization of the failing heart.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

8.  Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial.

Authors:  Stefan Asbach; Maximilian Hartmann; Tobias Wengenmayer; Erika Graf; Christoph Bode; Juergen Biermann
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 9.  Device therapies: new indications and future directions.

Authors:  Prabhat Kumar; Jennifer D Schwartz
Journal:  Curr Cardiol Rev       Date:  2015

10.  Impact of acute changes of left ventricular contractility on the transvalvular impedance: validation study by pressure-volume loop analysis in healthy pigs.

Authors:  Vincenzo Lionetti; Simone Lorenzo Romano; Giacomo Bianchi; Fabio Bernini; Anar Dushpanova; Giuseppe Mascia; Martina Nesti; Franco Di Gregorio; Alberto Barbetta; Luigi Padeletti
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.